Reach Our Cytotoxic Experts:

cytotoxics@lonza.com

The Best of Both Worlds

Cytotoxic drugs act by directly killing selected cells, affecting both the growth and behavior of remaining cells to treat unwanted malignancies and tumors.  Cytotoxics can be used to treat various ailments including rheumatoid arthritis, and systemic lupus erythematous. They are commonly used in oncology therapeutics, which represent one of the fastest growing segments of the pharmaceutical and biotechnology industry.

While cytotoxic drugs have widespread treatment potential, the successful and safe manufacturing of cytotoxic drugs requires a highly skilled team of experts and well controlled manufacturing facilities.  Lonza currently operates GMP production suites for gram-scale cytotoxic production and recently invested CHF 24 million for multi-kilogram-scale production capacity at our site in Visp, Switzerland.  We continue to focus on safety of supply when meeting your clinical and commercial scale demands. 

For more information about our cytotoxic capabilities view our Cytotoxic Frequently Asked Questions.